HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of preoperative use of propranolol on postoperative outcome in patients with tetralogy of Fallot.

Abstract
The aim of this study was to determine if preoperative propranolol therapy has a deleterious effect on postoperative variables in patients with tetralogy of Fallot. Data from 97 patients who underwent complete repair of tetralogy of Fallot were reviewed. The patients were divided into 2 groups: those receiving preoperative propranolol therapy (n = 32) and those not receiving therapy (n = 65). Preoperative and intraoperative variables did not differ between groups. There were no differences in postoperative inotrope scores on arrival to the intensive care unit and through the first 12 hours postoperatively. There was a trend toward increased inotrope scores at 24 hours (median 8 vs 5, p = 0.05) and 48 hours (median 8 vs 3, p = 0.05) postoperatively in the patients treated with propranolol. Temporary pacing in the early postoperative period occurred more often in the propranolol group (16% vs 3%, p = 0.04). There was no difference between groups in length of mechanical ventilation, intensive care unit stay, or total hospital postoperative stay. In conclusion, propranolol therapy can be used in patients with tetralogy of Fallot until the time of surgery, without important effects on their postoperative courses. Any blunting of inotropic or chronotropic activity in propranolol-treated patients appears to be easily overcome with increased inotropic medications or temporary pacing, without increased morbidity or mortality.
AuthorsEric M Graham, Varsha M Bandisode, Scott M Bradley, Fred A Crawford Jr, Janet M Simsic, Andrew M Atz
JournalThe American journal of cardiology (Am J Cardiol) Vol. 101 Issue 5 Pg. 693-5 (Mar 01 2008) ISSN: 0002-9149 [Print] United States
PMID18308023 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Cardiotonic Agents
  • Propranolol
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Cardiotonic Agents (therapeutic use)
  • Child, Preschool
  • Drug Administration Schedule
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Intensive Care Units
  • Male
  • Outcome Assessment, Health Care
  • Postoperative Care
  • Premedication
  • Propranolol (therapeutic use)
  • Retrospective Studies
  • Tetralogy of Fallot (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: